Identification of Liver Fibrosis Biomarkers

Not yet recruitingOBSERVATIONAL
Enrollment

575

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Non-alcoholic Fatty LiverNon-Alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Interventions
OTHER

Identification of liver fibrosis biomarkers

"Patients will be recruited in the study using 2 different approaches. The first is patients who are referred to clinical centers as part of an existing assessment where a decision to perform a liver biopsy has been made (routine biopsy). This decision can be based on standard liver function tests AST, ALT, FIB-4 (performed up to 8 months before biopsy), fibroscan (performed up to 6 months before biopsy) or other factors.~In addition, patients F0-F2 who underwent a biopsy within the last 6 months but at least 1 month ago, can be recalled to join the study. If patients agree to participate in the study, they will be recalled to the site for a blood draw and ultrasound scan."

All Listed Sponsors
lead

Roche Diagnostics GmbH

INDUSTRY

NCT06819917 - Identification of Liver Fibrosis Biomarkers | Biotech Hunter | Biotech Hunter